Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P63155

Entry ID Method Resolution Chain Position Source
AF-P63155-F1 Predicted AlphaFoldDB

No variants for P63155

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for P63155

No associated diseases with P63155

13 regional properties for P63155

Type Name Position InterPro Accession
repeat HAT (Half-A-TPR) repeat 61 - 93 IPR003107-1
repeat HAT (Half-A-TPR) repeat 95 - 127 IPR003107-2
repeat HAT (Half-A-TPR) repeat 129 - 161 IPR003107-3
repeat HAT (Half-A-TPR) repeat 163 - 194 IPR003107-4
repeat HAT (Half-A-TPR) repeat 196 - 227 IPR003107-5
repeat HAT (Half-A-TPR) repeat 229 - 264 IPR003107-6
repeat HAT (Half-A-TPR) repeat 266 - 300 IPR003107-7
repeat HAT (Half-A-TPR) repeat 344 - 378 IPR003107-8
repeat HAT (Half-A-TPR) repeat 388 - 424 IPR003107-9
repeat HAT (Half-A-TPR) repeat 426 - 457 IPR003107-10
repeat HAT (Half-A-TPR) repeat 459 - 491 IPR003107-11
repeat HAT (Half-A-TPR) repeat 493 - 527 IPR003107-12
repeat HAT (Half-A-TPR) repeat 529 - 560 IPR003107-13

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Nucleus speckle
  • Colocalizes with core spliceosomal snRNP proteins
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
catalytic step 2 spliceosome A spliceosomal complex that contains three snRNPs, including U5, bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the associated snRNPs.
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
post-mRNA release spliceosomal complex A spliceosomal complex that is formed following the release of the spliced product from the post-spliceosomal complex and contains the excised intron and three snRNPs, including U5.
Prp19 complex A protein complex consisting of Prp19 and associated proteins that is involved in the transition from the precatalytic spliceosome to the activated form that catalyzes step 1 of splicing, and which remains associated with the spliceosome through the second catalytic step. It is widely conserved, found in both yeast and mammals, though the exact composition varies. In S. cerevisiae, it contains Prp19p, Ntc20p, Snt309p, Isy1p, Syf2p, Cwc2p, Prp46p, Clf1p, Cef1p, and Syf1p.
spliceosomal complex Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA.
U2-type catalytic step 2 spliceosome A spliceosomal complex that contains the U2, U5 and U6 snRNPs bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the U2, U5 and U6 snRNPs.

1 GO annotations of molecular function

Name Definition
RNA binding Binding to an RNA molecule or a portion thereof.

5 GO annotations of biological process

Name Definition
cellular response to brain-derived neurotrophic factor stimulus A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a brain-derived neurotrophic factor stimulus.
cellular response to leukemia inhibitory factor Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
cerebral cortex development The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.
mRNA splicing, via spliceosome The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.
spliceosomal complex assembly The aggregation, arrangement and bonding together of a spliceosomal complex, a ribonucleoprotein apparatus that catalyzes nuclear mRNA splicing via transesterification reactions.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P17886 crn Protein crooked neck Drosophila melanogaster (Fruit fly) PR
Q9BZJ0 CRNKL1 Crooked neck-like protein 1 Homo sapiens (Human) PR
P63154 Crnkl1 Crooked neck-like protein 1 Mus musculus (Mouse) PR
Q99PK0 Xab2 Pre-mRNA-splicing factor SYF1 Rattus norvegicus (Rat) PR
A1A5S1 Prpf6 Pre-mRNA-processing factor 6 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MAASTAAGKQ RIPKVAKVKN KAPAEVQITA EQLLREAKER ELELLPPPPQ QKITDEEELN
70 80 90 100 110 120
DYKLRKRKTF EDNIRKNRTV ISNWIKYAQW EESLKEIQRA RSIYERALDV DYRNITLWLK
130 140 150 160 170 180
YAEMEMKNRQ VNHARNIWDR AITTLPRVNQ FWYKYTYMEE MLGNVAGARQ VFERWMEWQP
190 200 210 220 230 240
EEQAWHSYIN FELRYKEVER ARTIYERFVL VHPAVKNWIK YARFEEKHAY FAHARKVYER
250 260 270 280 290 300
AVEFFGDEHM DEHLYVAFAK FEENQKEFER VRVIYKYALD RISKQEAQEL FKNYTIFEKK
310 320 330 340 350 360
FGDRRGIEDI IVSKRRFQYE EEVKANPHNY DAWFDYLRLV ESDAEADTVR EVYERAIANV
370 380 390 400 410 420
PPIQEKRHWK RYIYLWVNYA LYEELEAKDP ERTRQVYQAS LELIPHKKFT FAKMWLYYAQ
430 440 450 460 470 480
FEIRQKNLPF ARRALGTSIG KCPKNKLFKG YIELELQLRE FDRCRKLYEK FLEFGPENCT
490 500 510 520 530 540
SWIKFAELET ILGDIERARA IYELAISQPR LDMPEVLWKS YIDFEIEQEE TERTRNLYRQ
550 560 570 580 590 600
LLQRTQHVKV WISFAQFELS SGKEGSVAKC RQIYEEANKT MRNCEEKEER LMLLESWRSF
610 620 630 640 650 660
EDEFGTVSDK ERVDKLMPEK VKKRRKVQAD DGSDAGWEEY YDYIFPEDAA NQPNLKLLAM
670 680
AKLWKKQQQE REAAEQDPDK DIDESESSSF